← All trials
NCT03180424
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Aug 31, 2017
- Completion date
- Sep 30, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital de Clínicas Dr. Manuel QuintelaLead sponsor
- University of the Republic, UruguayCollaborator
- Hospital de Clínicas Dr. Manuel QuintelaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.